IMCgp100-401 Rollover Study

Clinical trial NCT02889861 · TERMINATED

Trial details

NCT number: NCT02889861
Sponsor: Immunocore Ltd
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2017-01-11
Primary completion: 2019-04-22
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.